Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact of tumor microenvironment composition on therapeutic responses and clinical outcomes in cancer
Authors
Keywords
-
Journal
Future Oncology
Volume 14, Issue 14, Pages 1409-1421
Publisher
Future Medicine Ltd
Online
2018-05-31
DOI
10.2217/fon-2017-0585
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second‐Line Treatment of MetastaticKRASMutant Colorectal Adenocarcinoma
- (2017) J. Randolph Hecht et al. ONCOLOGIST
- A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma
- (2017) Al B. Benson et al. ONCOLOGIST
- Interferon-γ is a master checkpoint regulator of cytokine-induced differentiation
- (2017) Zhao Zha et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ipilimumab treatment decreases monocytic MDSCs and increases CD8 effector memory T cells in long-term survivors with advanced melanoma
- (2017) Yago Pico de Coana et al. Oncotarget
- Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies – A review
- (2017) Ahmed M. Al-Abd et al. Journal of Advanced Research
- Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma
- (2016) Jeffrey J. Wallin et al. Nature Communications
- New horizons in tumor microenvironment biology: challenges and opportunities
- (2015) Fei Chen et al. BMC Medicine
- Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
- (2015) Bryan W Miller et al. EMBO Molecular Medicine
- Targeting the indoleamine 2,3-dioxygenase pathway in cancer
- (2015) Yong Wha Moon et al. Journal for ImmunoTherapy of Cancer
- Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
- (2015) Kazuyoshi Shiga et al. Cancers
- Remodeling Components of the Tumor Microenvironment to Enhance Cancer Therapy
- (2015) Vasiliki Gkretsi et al. Frontiers in Oncology
- Targeting ECM Disrupts Cancer Progression
- (2015) Freja A. Venning et al. Frontiers in Oncology
- Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
- (2014) Rakesh K. Jain CANCER CELL
- Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs
- (2014) Lei Lu et al. Journal of Translational Medicine
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Circulating Biomarkers of Tryptophan and the Kynurenine Pathway and Lung Cancer Risk
- (2013) S.-C. Chuang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
- (2013) Y. Huang et al. CANCER RESEARCH
- LOX-Mediated Collagen Crosslinking Is Responsible for Fibrosis-Enhanced Metastasis
- (2013) T. R. Cox et al. CANCER RESEARCH
- Suppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-α gene therapy for pancreatic cancer
- (2013) Kouichirou Aida et al. CANCER SCIENCE
- Carcinoma-associated fibroblasts: Non-neoplastic tumour-promoting mesenchymal cells
- (2013) Urszula M. Polanska et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
- (2012) M. Platten et al. CANCER RESEARCH
- T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
- (2012) A. Facciabene et al. CANCER RESEARCH
- Suppression, subversion and escape: the role of regulatory T cells in cancer progression
- (2012) K. Oleinika et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Targeting the Tumor Microenvironment for Cancer Therapy
- (2012) N. E. Sounni et al. CLINICAL CHEMISTRY
- Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
- (2012) Michael A Jacobetz et al. GUT
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Glioblastoma survival in the United States before and during the temozolomide era
- (2011) Derek R. Johnson et al. JOURNAL OF NEURO-ONCOLOGY
- A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
- (2011) Omid Hamid et al. Journal of Translational Medicine
- Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas
- (2011) Klaus Laimer et al. ORAL ONCOLOGY
- Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy
- (2010) David Coe et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The extracellular matrix in development and morphogenesis: A dynamic view
- (2009) Tania Rozario et al. DEVELOPMENTAL BIOLOGY
- Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
- (2009) Maria A. Curotto de Lafaille et al. IMMUNITY
- Genotyping and Expression Analysis of IDO2 in Human Pancreatic Cancer: A Novel, Active Target
- (2009) Agnieszka K. Witkiewicz et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Combined Anti-Angiogenic Therapy Targeting PDGF and VEGF Receptors Lowers the Interstitial Fluid Pressure in a Murine Experimental Carcinoma
- (2009) Agnieszka Kłosowska-Wardęga et al. PLoS One
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- GITR ligand-costimulation activates effector and regulatory functions of CD4+ T cells
- (2008) Hanna Igarashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005)
- (2008) Arie S. Belldegrun et al. CANCER
- Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival
- (2008) K. Ino et al. CLINICAL CANCER RESEARCH
- Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy
- (2008) M. Egeblad et al. Disease Models & Mechanisms
- Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma
- (2008) Ke Pan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started